Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000614493) titled 'Effect of Artificial Intelligence-guided Cardio-Diabetic Disease Management Program on Follow-up Functional Capacity in People with Diabetes' on June 13.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: University of Tasmania
Condition:
Type 2 diabetes mellitus (T2DM)
Heart failure (HF)
Type 2 diabetes mellitus (T2DM)
Heart failure (HF)
Cardiovascular - Other cardiovascular diseases
Metabolic and Endocrine - Diabetes
Intervention:
The multidisciplinary ca...